What testing does Virtus Peptides run on MT-2
It considers variables such as age, weight, medical history, and sometimes lab results to provide a tailored dosage recommendation
The drugs mimic a gut hormone called glucagon-like peptide 1, which acts on the brain to dampen appetite, in addition to controlling blood sugar levels
Studies in mice with CNS neuron-specific GLP-1R knockout showed that liraglutide failed to induce weight loss but still improved glucose levels, suggesting that brain GLP-1Rs are necessary for the weight-lowering effect of GLP-1RAs but not essential for their glucose-lowering effects (142)
Pros: One of the most extensively studied healing peptides in animal and in vitro models, with a broad published mechanistic literature Reported to have a favorable short-term tolerability profile in the limited human data available, with side effects typically mild and self-limiting Available in both injectable and oral research formulations, offering flexibility for different use cases Cons: No completed Phase 2 or Phase 3 human clinical trials exist